Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Annals of the Rheumatic Diseases|September 6, 2024
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful diseaseKevin D Deane, V Michael Holers, Paul Emery, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Nature Communications|February 5, 2014
TNF-α blockade induces IL-10 expression in human CD4+ T cellsHayley G Evans, Urmas Roostalu, Gina J Walter, et al.
The Lancet. Rheumatology|December 21, 2020
Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional studyPhilippa M Wells, Adewale S Adebayo, Ruth C E Bowyer, et al.
Plos Genetics|September 27, 2013
Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smokingIan C Scott, Seth D Seegobin, Sophia Steer, et al.
Blood|January 27, 2007
TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissuesZhuoli Zhang, Claire L Gorman, Anna-Chiara Vermi, et al.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
Arthritis Research & Therapy|October 10, 2021
Correction to: The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patientsBianka Marklein, Madeleine Jenning, Zoltán Konthur, et al.
Arthritis Research & Therapy|September 15, 2021
The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patientsBianka Marklein, Madeleine Jenning, Zoltán Konthur, et al.
The Lancet. Rheumatology|November 30, 2022
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYMark D Russell, James B Galloway, Colm D Andrews, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Annals of the Rheumatic Diseases|September 6, 2024
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful diseaseKevin D Deane, V Michael Holers, Paul Emery, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Nature Communications|February 5, 2014
TNF-α blockade induces IL-10 expression in human CD4+ T cellsHayley G Evans, Urmas Roostalu, Gina J Walter, et al.
The Lancet. Rheumatology|December 21, 2020
Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional studyPhilippa M Wells, Adewale S Adebayo, Ruth C E Bowyer, et al.
Plos Genetics|September 27, 2013
Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smokingIan C Scott, Seth D Seegobin, Sophia Steer, et al.
Blood|January 27, 2007
TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissuesZhuoli Zhang, Claire L Gorman, Anna-Chiara Vermi, et al.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
Arthritis Research & Therapy|October 10, 2021
Correction to: The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patientsBianka Marklein, Madeleine Jenning, Zoltán Konthur, et al.
Arthritis Research & Therapy|September 15, 2021
The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patientsBianka Marklein, Madeleine Jenning, Zoltán Konthur, et al.
The Lancet. Rheumatology|November 30, 2022
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYMark D Russell, James B Galloway, Colm D Andrews, et al.
Pageof 19